The NADPH Oxidase Nox4 mediates tumour angiogenesis

Acta Physiologica

Volumn 216, Issue 4, 2016, Pages 435-446

  Helfinger, V ^a   Henke, N ^a   Harenkamp, S ^a   Walter, M ^a   Epah, J ^a   Penski, C ^a   Mittelbronn, M ^a   Schroder K ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cancer; Hypoxia inducible factor 1 ; NADPH oxidase Nox4; Tumour angiogenesis

Indexed keywords

3 METHYLCHOLANTHRENE; ADRENOMEDULLIN; CARCINOGEN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; VASCULOTROPIN A; NOX4 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SIZE; CANCER THERAPY; CARCINOGENESIS; DRUG TARGETING; FIBROSARCOMA; GENE ACTIVATION; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; VASCULARIZATION; WILD TYPE; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION;

EID: 84959492850     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12625     Document Type: Article

References (40)

1. Al-Shabrawey, M, Bartoli, M, El-Remessy, AB, Platt, DH, Matragoon, S, Behzadian, MA, Caldwell, RW & Caldwell, RB 2005. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol167, 599-607.
2. Al-Shabrawey, M, Bartoli, M, El-Remessy, AB, Ma, G, Matragoon, S, Lemtalsi, T, Caldwell, RW & Caldwell, RB 2008. Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Invest Ophthalmol Vis Sci 49, 3231-3238.
3. Arbiser, JL, Petros, J, Klafter, R, Govindajaran, B, McLaughlin, ER, Brown, LF, Cohen, C, Moses, M, Kilroy, S, Arnold, RS & Lambeth, JD 2002. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99, 715-720.
4. Bedard, K & Krause, K-H 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313.
5. Bonello, S, Zähringer, C, BelAiba, RS, Djordjevic, T, Hess, J, Michiels, C, Kietzmann, T & Görlach, A 2007. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27, 755-761.
6. Bradford, MM 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
7. Carmeliet, P 2005. Angiogenesis in life, disease and medicine. Nature 438, 932-936.
8. Carmeliet, P, Dor, Y, Herbert, JM, Fukumura, D, Brusselmans, K, Dewerchin, M, Neeman, M, Bono, F, Abramovitch, R, Maxwell, P et al. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490.
9. Chua, CC, Hamdy, RC & Chua, BH 1998. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 25, 891-897.
10. Diebold, I, Petry, A, Hess, J & Görlach, A 2010. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 21, 2087-2096.
11. Forsythe, JA, Jiang, BH, Iyer, NV, Agani, F, Leung, SW, Koos, RD & Semenza, GL 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604-4613.
12. Fukumura, D, Xavier, R, Sugiura, T, Chen, Y, Park, EC, Lu, N, Selig, M, Nielsen, G, Taksir, T, Jain, RK & Seed, B 1998. Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715-725.
13. Garrido-Urbani, S, Jemelin, S, Deffert, C, Carnesecchi, S, Basset, O, Szyndralewiez, C, Heitz, F, Page, P, Montet, X, Michalik, L, Arbiser, J, Rüegg, C, Krause, KH, Imhof, BA & Imhof, B 2011. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism. PLoS ONE 6, e14665.
14. Gavazzi, G, Deffert, C, Trocme, C, Schäppi, M, Herrmann, FR & Krause, K-H 2007. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50, 189-196.
15. Görlach, A, Diebold, I, Schini-Kerth, VB, Berchner-Pfannschmidt, U, Roth, U, Brandes, RP, Kietzmann, T & Busse, R 2001. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 89, 47-54.
16. Goyal, P, Weissmann, N, Grimminger, F, Hegel, C, Bader, L, Rose, F, Fink, L, Ghofrani, HA, Schermuly, RT, Schmidt Harald, HHW, Seeger, W & Hänze, J 2004. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic Biol Med 36, 1279-1288.
17. Ito, T-K, Ishii, G, Chiba, H & Ochiai, A 2007. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 26, 7194-7203.
18. Jung, S-N, Yang, WK, Kim, J, Kim, HS, Kim, EJ, Yun, H, Park, H, Kim, SS, Choe, W, Kang, I & Ha, J 2008. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29, 713-721.
19. Kung, AL, Wang, S, Klco, JM, Kaelin, WG & Livingston, DM 2000. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6, 1335-1340.
20. Leo, C, Giaccia, AJ & Denko, NC 2004. The hypoxic tumor microenvironment and gene expression. Semin Radiat Oncol 14, 207-214.
21. Malec, V, Gottschald, OR, Li, S, Rose, F, Seeger, W & Hänze, J 2010. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med 48, 1626-1635.
22. Oshikawa, J, Kim, S-J, Furuta, E, Caliceti, C, Chen, G-F, McKinney, RD, Kuhr, F, Levitan, I, Fukai, T & Ushio-Fukai, M 2012. Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 302, H724-H732.
23. Otrock, ZK, Mahfouz Rami, AR, Makarem, JA & Shamseddine, AI 2007. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol Dis 39, 212-220.
24. Schröder, K 2014. NADPH oxidases in redox regulation of cell adhesion and migration. Antioxid Redox Signal 20, 2043-2058.
25. Schröder, K, Helmcke, I, Palfi, K, Krause, K-H, Busse, R & Brandes, RP 2007. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27, 1736-1743.
26. Schröder, K, Kohnen, A, Aicher, A, Liehn, EA, Büchse, T, Stein, S, Weber, C, Dimmeler, S & Brandes, RP 2009. NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ Res 105, 537-544.
27. Schröder, K, Zhang, M, Benkhoff, S, Mieth, A, Pliquett, R, Kosowski, J, Kruse, C, Luedike, P, Michaelis, UR, Weissmann, N, Dimmeler, S, Shah, AM & Brandes, RP 2012. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110, 1217-1225.
28. Serrander, L, Cartier, L, Bedard, K, Banfi, B, Lardy, B, Plastre, O, Sienkiewicz, A, Fórró, L, Schlegel, W & Krause, K-H 2007. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406, 105-114.
29. Tojo, T, Ushio-Fukai, M, Yamaoka-Tojo, M, Ikeda, S, Patrushev, N & Alexander, RW 2005. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111, 2347-2355.
30. Ushio-Fukai, M & Alexander, RW 2004. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264, 85-97.
31. Ushio-Fukai, M & Nakamura, Y 2008. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266, 37-52.
32. Ushio-Fukai, M, Tang, Y, Fukai, T, Dikalov, SI, Ma, Y, Fujimoto, M, Quinn, MT, Pagano, PJ, Johnson, C & Alexander, RW 2002. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91, 1160-1167.
33. Veikkola, T & Alitalo, K 1999. VEGFs, receptors and angiogenesis. Semin Cancer Biol 9, 211-220.
34. Vogel, J, Kruse, C, Zhang, M & Schröder, K 2015. Nox4 supports proper capillary growth in exercise and retina neo-vascularization. J Physiol 593, 2145-2154.
35. Wang, GL, Jiang, BH, Rue, EA & Semenza, GL 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92, 5510-5514.
36. Webler, AC, Michaelis, UR, Popp, R, Barbosa-Sicard, E, Murugan, A, Falck, JR, Fisslthaler, B & Fleming, I 2008. Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. Am J Physiol Cell Physiol 295, C1292-C1301.
37. Welti, J, Loges, S, Dimmeler, S & Carmeliet, P 2013. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Investig 123, 3190-3200.
38. Wilkinson-Berka, JL, Deliyanti, D, Rana, I, Miller, AG, Agrotis, A, Armani, R, Szyndralewiez, C, Wingler, K, Touyz, RM, Cooper, ME, Jandeleit-Dahm, KA & Schmidt Harald, HHW 2014. NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. Antioxid Redox Signal 20, 2726-2740.
39. Xia, C, Meng, Q, Liu, L-Z, Rojanasakul, Y, Wang, X-R & Jiang, B-H 2007. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67, 10823-10830.
40. Zhang, M, Brewer, AC, Schröder, K, Santos Celio, XC, Grieve, DJ, Wang, M, Anilkumar, N, Yu, B, Dong, X, Walker, SJ, Brandes, RP & Shah, AM 2010. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 107, 18121-18126.